Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.
作者信息
Ryder S D
机构信息
Queens Medical Centre, Nottingham NG7 2UH, UK.
出版信息
Gut. 2003 May;52 Suppl 3(Suppl 3):iii1-8. doi: 10.1136/gut.52.suppl_3.iii1.
Abstract
摘要
相似文献
1
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.成人肝细胞癌（HCC）诊断和治疗指南
Gut. 2003 May;52 Suppl 3(Suppl 3):iii1-8. doi: 10.1136/gut.52.suppl_3.iii1.
2
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.肝细胞癌的流行病学、筛查、诊断与治疗
Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38.
3
Current approach to hepatocellular carcinoma.当前肝癌治疗方法。
Surg Clin North Am. 2010 Aug;90(4):803-16. doi: 10.1016/j.suc.2010.04.010. Epub 2010 Jun 8.
4
Hepatocellular cancer.肝细胞癌
West Indian Med J. 2009 Jun;58(3):273-6.
5
[Scrutiny and management of a patient with hepatocarcinoma].[肝癌患者的检查与管理]
Rev Gastroenterol Mex. 2005 Nov;70 Suppl 3:69-70.
6
Optimal management of hepatocellular carcinoma: challenges and opportunities.肝细胞癌的优化管理：挑战与机遇
J Gastroenterol Hepatol. 2010 Aug;25(8):1336-8. doi: 10.1111/j.1440-1746.2010.06373.x.
7
Management of hepatocellular carcinoma in the age of liver transplantation.肝移植时代肝细胞癌的管理
Int J Surg. 2009 Aug;7(4):324-9. doi: 10.1016/j.ijsu.2008.12.041. Epub 2009 Jan 6.
8
Hepatocellular carcinoma in a case of Wilson's disease treated with radiofrequency ablation therapy.肝豆状核变性患者肝细胞癌的射频消融治疗病例
Intern Med. 2011;50(13):1433-7. doi: 10.2169/internalmedicine.50.5203. Epub 2011 Jul 1.
9
Hepatocellular carcinoma: status in the era of liver transplantation.肝细胞癌：肝移植时代的现状
J Okla State Med Assoc. 2009 Dec;102(12):355-61.
10
Hepatocellular carcinoma: current management.肝细胞癌：当前的治疗方法
Curr Probl Surg. 2010 Jan;47(1):10-67. doi: 10.1067/j.cpsurg.2009.09.003.
引用本文的文献
1
Prevalence and risk factors of portal vein thrombosis following hepatectomy: a systematic review and meta‑analysis.肝切除术后门静脉血栓形成的患病率及危险因素：一项系统评价和荟萃分析
Wideochir Inne Tech Maloinwazyjne. 2025 Jan 15;20(1):36-43. doi: 10.20452/wiitm.2025.17929. eCollection 2025 Apr 9.
2
FCGR2A contributes to M2 macrophages polarization in HCC through IL-4/JAK/STAT6 axis.FCGR2A通过IL-4/JAK/STAT6轴促进肝癌中M2巨噬细胞极化。
Transl Oncol. 2025 Aug;58:102429. doi: 10.1016/j.tranon.2025.102429. Epub 2025 Jun 6.
3
Isolated calvarial lesion as the initial presentation of metastatic hepatocellular carcinoma: A case report and review of the literature.孤立性颅骨病变作为转移性肝细胞癌的首发表现：一例病例报告及文献复习
Surg Neurol Int. 2025 Jan 10;16:6. doi: 10.25259/SNI_507_2024. eCollection 2025.
4
Differentiating Well-Differentiated from Poorly-Differentiated HCC: The Potential and the Limitation of Gd-EOB-DTPA in the Presence of Liver Cirrhosis.鉴别高分化与低分化肝细胞癌：肝硬化情况下钆塞酸二钠的潜力与局限性
Diagnostics (Basel). 2024 Aug 2;14(15):1676. doi: 10.3390/diagnostics14151676.
5
Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective.肝脏疾病的当前及新出现的分子标志物：致病机制视角
Gene Expr. 2022;21(1):9-19. doi: 10.14218/gejlr.2022.00010. Epub 2022 Sep 28.
6
CASCADE: Context-Aware Data-Driven AI for Streamlined Multidisciplinary Tumor Board Recommendations in Oncology.CASCADE：用于肿瘤学中简化多学科肿瘤委员会建议的上下文感知数据驱动人工智能
Cancers (Basel). 2024 May 23;16(11):1975. doi: 10.3390/cancers16111975.
7
Ultrasensitive dynamic light scattering immunodetection of alpha-fetoprotein using heptamer-amplified nanoparticle crosslinking aggregation.利用七聚体放大的纳米颗粒交联聚集进行超灵敏动态光散射免疫检测甲胎蛋白。
Mikrochim Acta. 2024 Jun 13;191(7):387. doi: 10.1007/s00604-024-06437-7.
8
The Synergy of Gene Targeting Drug Icaritin Soft Capsule with Immunomodulator and TACE Brings New Hope for Drug Combination in Patients with Advanced Liver Cancer: A Case Report and Literature Review.基因靶向药物伊卡替尼软胶囊与免疫调节剂及经动脉化疗栓塞术联合应用为晚期肝癌患者的药物联合治疗带来新希望：1例病例报告及文献综述
Cancer Manag Res. 2023 Jul 18;15:707-717. doi: 10.2147/CMAR.S414487. eCollection 2023.
9
Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma.肝细胞癌局部区域治疗的最新进展
Cancers (Basel). 2023 Jun 26;15(13):3347. doi: 10.3390/cancers15133347.
10
A convoluted path to the diagnosis of hepatocellular carcinoma in a resource-limited setting.在资源有限的情况下诊断肝细胞癌的曲折之路。
SAGE Open Med Case Rep. 2023 Apr 25;11:2050313X231168292. doi: 10.1177/2050313X231168292. eCollection 2023.
本文引用的文献
1
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.长效奥曲肽治疗晚期肝细胞癌的随机安慰剂对照研究。
Hepatology. 2002 Sep;36(3):687-91. doi: 10.1053/jhep.2002.35071.
2
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.不可切除肝细胞癌患者的动脉栓塞或化疗栓塞与对症治疗对比：一项随机对照试验
Lancet. 2002 May 18;359(9319):1734-9. doi: 10.1016/S0140-6736(02)08649-X.
3
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.经动脉碘油化疗栓塞术治疗不可切除肝细胞癌的随机对照试验
Hepatology. 2002 May;35(5):1164-71. doi: 10.1053/jhep.2002.33156.
4
Short-term results of radiofrequency ablation in liver tumors.肝脏肿瘤射频消融的短期结果
Am J Surg. 2000 Jun;179(6):527. doi: 10.1016/s0002-9610(00)00254-3.
5
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.通过过继性免疫疗法降低肝细胞癌术后复发率：一项随机试验
Lancet. 2000 Sep 2;356(9232):802-7. doi: 10.1016/S0140-6736(00)02654-4.
6
Percutaneous microwave coagulation therapy for superficial hepatocellular carcinoma on the liver surface.经皮微波凝固疗法治疗肝脏表面的浅表性肝细胞癌
Am J Gastroenterol. 2000 Sep;95(9):2401-3. doi: 10.1111/j.1572-0241.2000.02355.x.
7
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.110例肝硬化患者肝细胞癌的射频消融治疗
Ann Surg. 2000 Sep;232(3):381-91. doi: 10.1097/00000658-200009000-00010.
8
Effectiveness of interferon therapy for reducing the incidence of hepatocellular carcinoma among patients with type C chronic hepatitis.干扰素治疗对降低丙型慢性肝炎患者肝细胞癌发病率的有效性。
J Epidemiol. 2000 Jul;10(4):234-40. doi: 10.2188/jea.10.234.
9
10
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.不可切除肝细胞癌的自然病程：肿瘤中雌激素受体状态是生存的最强预后因素。
Hepatology. 2000 Aug;32(2):233-8. doi: 10.1053/jhep.2000.9603.
Zotero 插件